Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stathopoulos

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 22, 2013
Maintenance chemotherapy or not in ovarian cancer stages IIIA, B, C, and IV after disease recurrenceG P Stathopoulos, Ch Papadimitriou, G Aravantinos, et al.
Oncology Reports|November 18, 2004
Long-term survival of patients with advanced colorectal cancer may not be due to the response to chemotherapyGeorge P Stathopoulos, Sotiris K Rigatos, Nicos A Malamos, et al.
Oncology|May 8, 2001
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancerG Fountzilas, C Papadimitriou, G Aravantinos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, G Stathopoulos, C Nicolaides, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic CancerG P Stathopoulos, S K Rigatos, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, D Skarlos, A Athanassiades, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II studyG Fountzilas, D Tsavdaridis, A Kalogera-Fountzila, et al.
Cancer|April 1, 1983
Pre- and postoperative chemoendocrine treatment with or without postoperative radiotherapy for locally advanced breast cancerA Papaioannou, B Lissaios, S Vasilaros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2006
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, P Papakostas, U Dafni, et al.
American Journal of Clinical Oncology|February 6, 2004
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 studyGeorge Fountzilas, G Stathopoulos, G Kouvatseas, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|January 22, 2013
Maintenance chemotherapy or not in ovarian cancer stages IIIA, B, C, and IV after disease recurrenceG P Stathopoulos, Ch Papadimitriou, G Aravantinos, et al.
Oncology Reports|November 18, 2004
Long-term survival of patients with advanced colorectal cancer may not be due to the response to chemotherapyGeorge P Stathopoulos, Sotiris K Rigatos, Nicos A Malamos, et al.
Oncology|May 8, 2001
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancerG Fountzilas, C Papadimitriou, G Aravantinos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 17, 1999
Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: a phase II study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, G Stathopoulos, C Nicolaides, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic CancerG P Stathopoulos, S K Rigatos, M A Dimopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck. A phase II study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, D Skarlos, A Athanassiades, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2002
Weekly paclitaxel as first-line chemotherapy and trastuzumab in patients with advanced breast cancer. A Hellenic Cooperative Oncology Group phase II studyG Fountzilas, D Tsavdaridis, A Kalogera-Fountzila, et al.
Cancer|April 1, 1983
Pre- and postoperative chemoendocrine treatment with or without postoperative radiotherapy for locally advanced breast cancerA Papaioannou, B Lissaios, S Vasilaros, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2006
Paclitaxel and gemcitabine vs. paclitaxel and pegylated liposomal doxorubicin in advanced non-nasopharyngeal head and neck cancer. An efficacy and cost analysis randomized study conducted by the Hellenic Cooperative Oncology GroupG Fountzilas, P Papakostas, U Dafni, et al.
American Journal of Clinical Oncology|February 6, 2004
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 studyGeorge Fountzilas, G Stathopoulos, G Kouvatseas, et al.
Pageof 5